Literature DB >> 21259248

Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinoma.

Jae Min Chun1, Hyung Jun Kwon, Junho Sohn, Sang Geol Kim, Ji-Young Park, Han Ik Bae, Young Kook Yun, Yoon Jin Hwang.   

Abstract

BACKGROUND: The prognosis of the patients with early recurrence after curative hepatectomy for hepatocellular carcinoma (HCC) is usually dismal.
METHODS: One hundred twenty-four patients underwent curative resection for HCC at Kyungpook National University Hospital from January 2002 to December 2006. An early recurrence was defined as a recurrence within 2 years after a curative resection. The risk factors associated with an early recurrence were analyzed as well as other risk factors correlated with survival after early recurrence.
RESULTS: Early disease recurrence developed in 56 patients (45.2%). The risk factors associated with an early recurrence were a tumor size larger than 5 cm (P = 0.001) and the presence of tumor micrometastasis (P < 0.001). The 1 year/2 year overall survival, after early recurrence, was 57.0%/41.0% and the preoperative α-fetoprotein, C-reactive protein (CRP), tumor size, macroscopic vascular invasion, and number of tumors were associated with survival on the univariate analysis. The multivariate analysis showed that the independent risk factors for survival, after early disease recurrence, were a preoperative CRP >1.0 mg/dl and macroscopic vascular invasion. (P = 0.004, P < 0.001, respectively).
CONCLUSION: The preoperative CRP and macroscopic vascular invasion were associated with the aggressiveness of early recurrent HCC.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21259248     DOI: 10.1002/jso.21786

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  37 in total

1.  Long-term results of laparoscopic hepatectomy versus open hepatectomy for hepatocellular carcinoma: a case-matched analysis.

Authors:  Kit Fai Lee; Ching Ning Chong; Jeff Wong; Yue Sun Cheung; John Wong; Paul Lai
Journal:  World J Surg       Date:  2011-10       Impact factor: 3.352

Review 2.  Noncoding RNA as therapeutic targets for hepatocellular carcinoma.

Authors:  Joseph George; Tushar Patel
Journal:  Semin Liver Dis       Date:  2015-01-29       Impact factor: 6.115

Review 3.  Liver transplantation for advanced hepatocellular carcinoma: how far can we go?

Authors:  Kyung-Suk Suh; Hae Won Lee
Journal:  Hepat Oncol       Date:  2015-01-12

4.  Side population in hepatocellular carcinoma HCCLM3 cells is enriched with stem-like cancer cells.

Authors:  Zhe Guo; Jing-Hang Jiang; Jun Zhang; Hao-Jie Yang; Yan-Ping Zhong; Jie Su; Ri-Rong Yang; LE-Qun Li; Bang-DE Xiang
Journal:  Oncol Lett       Date:  2016-03-17       Impact factor: 2.967

5.  MTBP inhibits migration and metastasis of hepatocellular carcinoma.

Authors:  Qian Bi; Atul Ranjan; Rui Fan; Neeraj Agarwal; Danny R Welch; Steven A Weinman; Jie Ding; Tomoo Iwakuma
Journal:  Clin Exp Metastasis       Date:  2015-03-11       Impact factor: 5.150

6.  Cancer stem cell markers correlate with early recurrence and survival in hepatocellular carcinoma.

Authors:  Zhe Guo; Le-Qun Li; Jing-Hang Jiang; Chao Ou; Li-Xia Zeng; Bang-De Xiang
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

7.  Clinicopathological significance and prognostic value of the expression of the cancer stem cell marker CD133 in hepatocellular carcinoma: a meta-analysis.

Authors:  Chen Zhong; Jin-Dao Wu; Ming-Ming Fang; Li-Yong Pu
Journal:  Tumour Biol       Date:  2015-04-29

8.  Clinicopathological predictors of poor survival and recurrence after curative resection in hepatocellular carcinoma without portal vein tumor thrombosis.

Authors:  Li Zhou; Jing-An Rui; Shao-Bin Wang; Shu-Guang Chen; Qiang Qu
Journal:  Pathol Oncol Res       Date:  2014-06-08       Impact factor: 3.201

9.  Oral supplementation of branched-chain amino acids reduces early recurrence after hepatic resection in patients with hepatocellular carcinoma: a prospective study.

Authors:  Kengo Ichikawa; Takehiro Okabayashi; Hiromichi Maeda; Tsutomu Namikawa; Tatsuo Iiyama; Takeki Sugimoto; Michiya Kobayashi; Toshiki Mimura; Kazuhiro Hanazaki
Journal:  Surg Today       Date:  2012-08-14       Impact factor: 2.549

10.  Chronic ingestion of ethanol induces hepatocellular carcinoma in mice without additional hepatic insult.

Authors:  Mutsumi Tsuchishima; Joseph George; Hisakazu Shiroeda; Tomiyasu Arisawa; Tsutomu Takegami; Mikihiro Tsutsumi
Journal:  Dig Dis Sci       Date:  2013-01-31       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.